Delineating psychopathologic clusters within dysthymia: A study of 512 out-patients without major depression

Journal of Affective Disorders

Volumn 56, Issue 1, 1999, Pages 17-25

  Serretti, A ^a   Jori, M C ^b   Casadei, G ^b   Ravizza, L ^c   Smeraldi, E ^a   Akiskal, H ^d  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b Sasol SpA   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anxiety; Cognitive symptoms; Dysthymia; Fatigue; Major depression; Mood; Neurasthenia

Indexed keywords

AMISULPRIDE; AMITRIPTYLINE; FLUOXETINE;

ADULT; AGED; ANXIETY; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DYSTHYMIA; FACTORIAL ANALYSIS; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MOOD; MULTICENTER STUDY; NEURASTHENIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY;

ADULT; AFFECT; ANXIETY; COMORBIDITY; DEPRESSION; DYSTHYMIC DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 0032697670     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(99)00056-7     Document Type: Article

References (40)

1. Akiskal H., Rosenthal T., Haykal R., Lemmi H., Rosenthal R., Scott-Strauss A. Characterological depressions: clinical and sleep EEG findings separating 'subaffective dysthymias' from 'character-spectrum' disorders. Arch. Gen. Psychiatry. 37:1980;777-783.
2. Akiskal H. Dysthymic disorder. Am. J. Psychiatry. 140:1993;11-20.
3. Akiskal H., Cassano G. Dysthymia and the Spectrum of Chronic Depressions. 1997;The Guilford Press, New York.
4. American Psychiatric Association, 1980. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed. APA, Washington DC.
5. American Psychiatric Association, 1987. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed., revised. APA, Washington DC.
6. American Psychiatric Association, 1994. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. APA, Washington DC.
7. Baksih D., Ravindran A., Hooper C., Lapierre Y. Psychopharmacologic treatment response of patients with DSM-III diagnosis of dysthymic disorder. Psychopharm. Bull. 30:1994;53-59.
8. Beck A., Brown G., Berchick R. Self-reported depression in symptoms that differentiate relevant episode major depression from dysthymic disorders. J. Clin. Psychol. 43:1987;246-250.
9. Brunello, N., Akiskal, H., Boyer, P., Gessa, G., Howland, R., Langer, S., Mendlewicz Paes de Souza, M., Placidi, G., Racagni, G., Wessley, S., in press. Dysthymia: clinical picture, extent of overlap with chronic fatigue syndrome, neuropharmacological considerations and new therapeutic vistas. J. Affect. Disord.
10. Chrzanowski G. Neurasthenia and hypochondria. Arieti S. American Handbook of Psychiatry. 1966;270-283 Basic Books, New York.
11. Clark D., Beck A., Beck J. Symptom differences in major depression, dysthymia, panic disorder, and generalized anxiety disorder. Am. J. Psychiatry. 151:1994;205-209.
12. Craighead W., Evans D. Factor analysis of the Montgomery-Asberg Depression Rating Scale. Depression. 4:1996;31-33.
13. Galinowski A., Lehert P. Structural validity of MADRS during antidepressant treatment. Int. Clin. Psychopharmacol. 10:1995;157-161.
14. Gjerris A., Bech P., Bojholm S., Bolwig T.G., Kramp P., Clemmesen L., Andersen J., Jensen E., Rafaelsen O.J. The Hamilton Anxiety Scale. Evaluation of homogeneity and inter-observer reliability in patients with depressive disorders. J. Affect. Disord. 5:1983;163-170.
15. Gwirtsman H., Blehar M., McCullough J., Kocsis J., Prien R. Standardized assessment of dysthymia: report of a National Institute of Mental Health conference. Psychopharmacol. Bull. 33:1997;3-11.
16. Hamilton M. The assessment of anxiety states by rating. Br. J. Med. Psychol. 32:1959;50-55.
17. Hamilton M. Diagnosis and rating of anxiety. Br. J. Psychiatry. 3:1969;76-79.
18. Kocsis J., Frances A., Voss C., et al. Imipramine treatment for chronic depression. Arch. Gen. Psychiatry. 45:1988;253-257.
19. Han L., Schmaling K., Dunner D. Descriptive validity and stability of diagnostic criteria for dysthymic disorder. Comp. Psychiatry. 36:1995;338-343.
20. Howland R. General health, healthcare utilization and medical comorbidity in dysthymia. Int. J. Psychiatry Med. 23:1993;211-238.
21. Keller M. Dysthymia in clinical practice: course, outcome and impact on the community. Acta Psychiatr. Scand. 89:(Suppl. 383):1994;24-34.
22. Keller M., Klein D., Hirschfeld R., Kocsis J., McCullough J., Miller I., First M., Holzer C.r., Keitner G., Marin D., Shea T. Results of the DSM-IV mood disorders field trial. Am. J. Psychiatry. 152:1995;843-849.
23. Kessler R., McGonagle K., Zhao S., Nelson C., Hughes M., Eshleman S., Wittchen H., Kendler K. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry. 51:1994;8-19.
24. Klein D., Kocsis J., McCullough J., Holzer C., Hirschfeld R., Keller M. Symptomatology in dysthymic and major depressive disorder. Psychiatr. Clin. North Am. 19:1996;41-53.
25. Klein D., Taylor E., Dickstein S., Harding K. The early-late onset distinction in DSM-III-R dysthymia. J. Affect. Disord. 14:1988;25-33.
26. Kovacs M., Akiskal H.S., Gatsonis C., Parrone P.L. Childhood-onset dysthymic disorder. Clinical features and prospective naturalistic outcome. Arch. Gen. Psychiatry. 51:1994;365-374.
27. Leader J., Klein D. Social adjustment in dysthymia, double depression and episodic major depression. J. Affect. Disord. 37:1996;91-101.
28. Lecrubier, Y., Boyer, P., Turjanski, S., Rein, W., in press. Amisulpiride versus imipramine and placebo in dysthymia and major depression. J. Affect. Disord.
29. Maier W., Buller R., Philipp M., Heuser I. The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders. J. Affect. Disord. 14:1988;61-68.
30. Mason B., Kocsis J., Leon A., Thompson S., Frances A., Morgan R., Parides M. Measurement of severity and treatment response in dysthymia. Psychiatr. Ann. 23:1993;625-631.
31. McCullough J., Braith J., Chapman R., Kasnetz M., Carr K., Cones J., Fielo J., Shoemaker O., Roberts W. Comparison of early and late onset dysthymia. J. Nerv. Ment. Dis. 178:1990;577-581.
32. Montgomery S., Asberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry. 134:1979;382-389.
33. Paykel E.S. Dysthymia in clinical practice: psychological therapies. Acta Psychiatr. Scand. 89:(Suppl. 383):1994;35-41.
34. Ravizza L. Amisulpride vs. amitriptyline in the medium-term treatment of dysthymia: a safety study. Biol. Psychiatry. 42:(Suppl.):1997;242S.
35. Sheehan D.V. The Anxiety Disease. 1983;Scribner, New York.
36. Smeraldi E. Amisulpiride versus fluoxetine in patients with dysthymia or major depression in partial remission: a double-blind, comparative study. J. Affect. Disord. 48:1998;47-56.
37. Szádóczky E., Fazekas I., Rihmer Z., Arato M. The role of psychosocial and biological variables in separating chronic and nonchronic major depression and early-late-onset dysthymia. J. Affect. Disord. 32:1994;1-11.
38. Vanelle J., Attar-levy D., Poirier M., Bouhassira M., Blin P., Olié J. Controlled efficacy study of fluoxetine in dysthymia. Br. J. Psychiatry. 170:1997;351-357.
39. Versiani M., Amrein R., Stabl M. Moclobemide and imipramine in chronic depression (dysthymia): an international double-blind, placebo-controlled trial. Int. Clin. Psychopharmacol. 12:1997;183-193.
40. World Health Organization, 1992. International Classification of Diseases, 10th ed. (ICD-10). WHO, Geneva.